Cytiva Cell datasheets catalogs app notes

  1. Oligonucleotide Synthesizers That Take You From Start To Finish 2/10/2023

    Explore systems for automated oligonucleotide synthesis, offered at a range of scales to support easy process development, optimization, scale up and transfer. Find the system that matches your needs.

  2. Chromatography Resins For Efficient Purification Of Oligonucleotides 2/10/2023

    The rise in approved oligo therapeutics has led to increased pressure on oligo manufacturers. Learn about modern chromatography resins, how they can help increase productivity in manufacturing, and more.

  3. Accelerate Your Oligonucleotide Development And Scale-Up Goals 2/10/2023

    Discover the platform for oligonucleotide development and scale-up that is the result of 30 years of collaboration with leading oligonucleotide pharma. Explore this solution's benefits, specifications, and more.

  4. Understanding The Microfluidic Platforms For Scaling Nanoparticle Production 10/13/2022

    Learn about the benefits of microfluidics for nanoparticle production over traditional methods as well as scaling nanoparticle production for clinical or industrial use.

  5. Genome Editing of Human Primary T Cells With Lipid Nanoparticles 4/18/2022

    We show CRISPR/Cas9-mediated knockouts of the T cell receptor and explore multi-step LNP engineering to produce TCRɑβ KO CAR T cells, a promising approach towards allogeneic CAR T cell therapy.

  6. Low-Volume Production For Screening High-Value Nanoparticle Materials 4/18/2022

    A platform that harnesses microfluidic mixing has been demonstrated as a simple, robust, and scalable production method for LNPs encapsulating various types of nucleic acids.

  7. ÄKTA oligosynt™ Oligonucleotide Synthesizer 3/28/2022

    The system supports a robust and easily scalable oligonucleotide synthesis process and transfer to larger oligonucleotide synthesizers with high yield and quality.

  8. Closed And Semi-Automated Processing Of CAR T Cells 7/5/2019

    Learn about a robust CAR T-cell manufacturing workflow that can be adapted for cGMP compliance in the commercial production of CAR T-cells.

  9. Alternative To Cryobags For Large Volume Cryopreservation 6/6/2019

    This study demonstrates an optimized cooling protocol for cryopreserving large-volume cryovials in a controlled-rate freezer, avoiding the need for liquid nitrogen.

  10. Workflow For Primary Human NK Cell Isolation, Xeno-Free Expansion, Harvest, And Cryopreservation 8/30/2018

    Obtaining primary human NK cells at clinically relevant scale is challenging. Find out how you can generate 109 cells using a xeno‑free NK cell expansion and several automated and functionally closed unit operations, suitable for cGMP environments.